Latest News
Latest News
Five questions for COVID experts: How concerned should we be?
“A challenge with COVID-19, all along, has been disparities in access to care, and this will be worse without public support for prevention and...
Latest News
FDA to step up oversight of cosmetics, assess ‘forever chemicals’
The cosmetic products include makeup products, nail polishes, shaving creams, other grooming products, perfumes, face and body cleansers, hair...
From the Journals
Industry funding falls for rheumatology research
Research-associated payments dipped by 24% from 2014 to 2022, new data suggest.
News from the FDA/CDC
FDA approves canakinumab for gout flares
Canakinumab is the first biologic in the U.S. approved for treating gout flares.
Guidelines
ACR releases guideline for managing ILD in patients with rheumatic disease
“Guidance was needed for which tests to use for screening and monitoring this particular disease,” said lead author Sindhu R. Johnson, MD, PhD....
Latest News
Medicare announces 10 drugs targeted for price cuts in 2026
People on Medicare may in 2026 see prices drop for 10 medicines, including pricey diabetes, cancer, blood clot, and arthritis treatments.
From the Journals
Interstitial lung disease plus pulmonary hypertension equals poor outcomes in systemic sclerosis
Female sex and higher body mass index were associated with lower mortality risk.
From the Journals
Slight weight gain, no blood pressure increase with low-dose steroids for RA
People with rheumatoid arthritis who take long-term, low-dose glucocorticoids do not appear to have significant...
From the Journals
Severe COVID may cause long-term cellular changes: Study
This study shows that after severe COVID, the immune system remains in ‘emergency mode’ and in a heightened state of inflammation.
Latest News
Rheumatology trials seem vulnerable to unblinding: Report
In an analysis of 14 published randomized controlled clinical trials of common rheumatology drugs, most had a high estimated risk for inadvertent...
News
Number of people with long COVID could be vastly underestimated
Patients with long COVID symptoms but without laboratory evidence of prior infection, “who have often been rejected and stigmatized, should feel...